Predicting treatment outcomes of major depressive disorder by early improvement in painful physical symptoms: A pooled analysis of double-blind, placebo-controlled trials of duloxetine
Neuropsychiatric Disease and Treatment Oct 05, 2017
Tokuoka H, et al. - In this work, researchers assess whether early improvement in painful physical symptoms (PPS) can be a predictor of remission in the treatment of major depressive disorder (MDD). In PPS, early improvement seemed a useful clinical indicator of subsequent treatment outcome for MDD patients with associated PPS.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries